ABBV ▼ -0.7% - AbbVie Inc.
$ABBV - Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications
AbbVie fell 0.7% today despite Allergan Aesthetics presenting new clinical data on skin quality improvements associated with medical weight loss medications. The mixed market reaction suggests investors may be weighing the potential upside from expanded aesthetics applications against broader concerns about the company's portfolio or near-term outlook.
17-SEP-2026 08:01 AM ET
Share this post
More filings for $ABBV
ABBV ▼ -0.1% - AbbVie Inc.Sep 17, 2026ABBV ▲ +0.0% - AbbVie Inc.Sep 15, 2026ABBV ▲ +0.0% - AbbVie Inc.Sep 15, 2026ABBV ▲ +0.9% - AbbVie Inc.Sep 10, 2026ABBV ▲ +0.4% - AbbVie Inc.Sep 10, 2026ABBV ▲ +0.3% - AbbVie Inc.Sep 3, 2026
View full $ABBV filing history →💬 Comments
Loading comments…
Leave a comment
